A novel drug could be used to treat neglected tropical diseases developed by researchers which can prompt genuine inability and affect more than 157 million individuals globally. University of Liverpool – UK, to deliver the first novel completely manufactured and soundly structured anti-Wolbachia drug, AWZ1066S, could potentially be used to cure onchocerciasis and lymphatic filariasis (LF). Onchocerciasis are caused by the filarial worm transmitted by repeated bites of infected blackflies and LF occurs when filarial parasites are transmitted to humans through mosquitoes. Steve Ward, researcher at University of Liverpool said,…
Read More